Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,736 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characterization of murine CEACAM1 in vivo reveals low expression on CD8+ T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1.
McLeod RL, Angagaw MH, Baral TN, Liu L, Moniz RJ, Laskey J, Hsieh S, Lee M, Han JH, Issafras H, Javaid S, Loboda A, Sadekova S, O'Connor JA, Tse A, Punnonen J. McLeod RL, et al. Among authors: han jh. Oncotarget. 2018 Oct 2;9(77):34459-34470. doi: 10.18632/oncotarget.26108. eCollection 2018 Oct 2. Oncotarget. 2018. PMID: 30349641 Free PMC article.
Long-chain polyunsaturated lipids associated with responsiveness to anti-PD-1 therapy are colocalized with immune infiltrates in the tumor microenvironment.
King ME, Yuan R, Chen J, Pradhan K, Sariol I, Li S, Chakraborty A, Ekpenyong O, Yearley JH, Wong JC, Zúñiga L, Tomazela D, Beaumont M, Han JH, Eberlin LS. King ME, et al. Among authors: han jh. J Biol Chem. 2023 Mar;299(3):102902. doi: 10.1016/j.jbc.2023.102902. Epub 2023 Jan 13. J Biol Chem. 2023. PMID: 36642178 Free PMC article.
Discovery and Evaluation of TLR-Targeted Immune Agonists.
Chernyak N, Bhagwat B, Naravula S, Chen Y, Solban N, Zhang F, Kofman E, Raoufi F, Dang X, Bao J, Tomazela D, Baily M, Geierstanger B, Flygare JA, Han JH, Willingham A, Seganish WM. Chernyak N, et al. Among authors: han jh. J Med Chem. 2024 Sep 26;67(18):16222-16234. doi: 10.1021/acs.jmedchem.4c00804. Epub 2024 Sep 5. J Med Chem. 2024. PMID: 39235949
Design and Optimization of Selectivity-Tunable Toll-like Receptor 7/8 Agonists as Novel Antibody-Drug Conjugate Payloads.
Patel AM, Willingham A, Cheng AC, Tomazela D, Bowman E, Kofman E, Zhang F, Bao J, Sanzone JR, Choy JW, Flygare JA, Han JH, Pradhan K, Kieffer M, Chernyak N, Akbari P, Liu P, Mehmood R, Naravula S, Hollingsworth SA, Bhagwat B, Lang SB, Seganish WM. Patel AM, et al. Among authors: han jh. J Med Chem. 2024 Sep 12;67(17):15756-15779. doi: 10.1021/acs.jmedchem.4c01384. Epub 2024 Aug 22. J Med Chem. 2024. PMID: 39172064
Clinical Potential of Novel Microbial Therapeutic LP51 Based on Xerosis-Microbiome Index.
Kim S, Rahim MA, Tajdozian H, Barman I, Park HA, Yoon Y, Jo S, Lee S, Shuvo MSH, Bae SH, Lee H, Ju S, Park CE, Kim HK, Han JH, Kim JW, Yoon SG, Kim JH, Choi YG, Lee S, Seo H, Song HY. Kim S, et al. Among authors: han jh. Cells. 2024 Dec 9;13(23):2029. doi: 10.3390/cells13232029. Cells. 2024. PMID: 39682776 Free PMC article. Clinical Trial.
2,736 results